Hagens Berman Alerts Investors With Losses Over $50,000 in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hagens Berman Alerts Investors With Losses Over $50,000 in Osiris Therapeutics, Inc. (NASDAQ: OSIR) of January 22, 2016 Lead Plaintiff Deadline

SAN FRANCISCO, Dec. 08, 2015 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors with losses over $50,000 of the January 22, 2016 lead plaintiff deadline in the securities fraud class action lawsuit filed against Osiris Therapeutics, Inc. (NASDAQ: OSIR ).

If you suffered losses because of your purchase of Osiris securities between May 12, 2014 and November 20, 2015 , contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation, by calling (510) 725-3000, emailing OSIR@hbsslaw.com or visiting https://www.hbsslaw.com/cases/OSIR . The lawsuit was filed in the U.S. District Court for the District of Maryland and investors have until January 22, 2016 to move the court to act as lead plaintiff .

The complaint accuses the defendants of violations of the securities laws because Osiris failed to disclose during the Class Period that the Company overstated revenues from several contracts and failed to follow Generally Accepted Accounting Principles.

The news shocked investors when announced on November 16, 2015. Osiris disclosed that if they correctly recognized revenue for three contracts, it would result in substantial decreases in product revenues in 2014 and the first and second quarters of 2015.  In addition, Osiris announced that these restatements would result in the Company missing its revenue targets in three of the last four quarters. Following this news of an accounting restatement, Osiris shares fell, dropping $3.02, or 21.53%, to close at $10.97 on November 17, 2015.

If you lost more than $50,000 in your investments in Osiris securities between May 12, 2014 and November 20, 2015 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Whistleblowers: Persons with non-public information regarding Osiris should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at (510) 725-3000 or email OSIR@hbsslaw.com .

About Hagens Berman Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com . Read the Firm’s Securities Newsletter at http://www.hbsslaw.com/hagens-berman-investor...newsletter , and visit the blog at www.meaningfuldisclosure.com . For the latest news visit http://www.hbsslaw.com/cases/pressreleases or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, (510) 725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capacitor Bank Market Growth Predictions Through 2033

Updated Category News Views 216

Capacitor Bank Market Set for Substantial Growth Recently, a comprehensive report highlighted the significant potential of the global capacitor bank market, forecasting a growth trajectory that sees its value increasing from $4.3 billion in 2023 to an impressive $6.8 billion by 2033. This translates to a compound annual growth rate (CAGR) of 4.8% during the period from...

Continue Reading
Understanding Rental Affordability Trends Across Major Markets

Updated Category News Views 291

Rental Affordability Trends in August 2024 As summer draws to a close, many renters are taking a close look at the housing market to gauge current affordability rates. A recent report highlights encouraging data, showing that rental affordability has generally improved in various major U.S. regions. This article outlines the key takeaways regarding rental affordability...

Continue Reading
Stallergenes Greer’s Palforzia® Gains European Approval for Toddlers

Updated Category News Views 134

Palforzia® Receives European Commission Approval for Toddlers Stallergenes Greer, a leader in allergen immunotherapy, has exciting news: the European Commission has officially approved the use of Palforzia® for toddlers aged 1 to 3 years with confirmed peanut allergies. This significant step enhances the treatment landscape for peanut allergies and opens new doors for...

Continue Reading
ProVen Growth and Income VCT's Latest Interim Management Insights

Updated Category News Views 174

ProVen Growth and Income VCT plc Overview ProVen Growth and Income VCT plc, known for its investment strategies and market presence, has released its Interim Management Statement for the recent quarter. This report highlights significant financial data and key developments that occurred from March to May 2025, offering shareholders insights into the company’s...

Continue Reading
Treefera Recognized as 2025 Gartner® Cool Vendor in Tech

Updated Category News Views 179

Treefera Honored as a 2025 Gartner® Cool Vendor Treefera has recently celebrated a significant milestone by being named a 2025 Gartner® Cool Vendor in Sourcing and Procurement Technology. This prestigious acknowledgment underscores Treefera's innovative contributions to the supply chain sector, particularly in providing first-mile visibility which is crucial for...

Continue Reading